Commissioner Bordelon was testifying about the recent decline in the number and cost of opioid drug prescriptions in the Texas workers’ compensation system that followed the adoption and implementation of the DWC’s Closed Drug Formulary.
The Texas Department of Insurance’s Workers’ Compensation Research and Evaluation Group recently completed and published the results of its study on the impact of the closed drug formulary.
author of this article ??
The article was drafted utilizing a press release from the Texas Department of Insurance’s Division of Workers’ Compensation (DWC).
See: http://www.tdi.texas.gov/news/2014/news201423.html.
Commissioner Bordelon was testifying about the recent decline in the number and cost of opioid drug prescriptions in the Texas workers’ compensation system that followed the adoption and implementation of the DWC’s Closed Drug Formulary.
The Texas Department of Insurance’s Workers’ Compensation Research and Evaluation Group recently completed and published the results of its study on the impact of the closed drug formulary.
See: http://www.tdi.texas.gov/reports/wcreg/documents/Pharma-mar2014.pdf.